Summary
We used the polymerase chain reaction (PCR) to study the presence and typing of human papillomavirus (HPV) DNA, and PCR/single-strand confirmation polymorphism to survey the mutations of the p53 gene in exons 5–9 in 26 bulky stage IB cervical cancers. The HPV DNA was present in 20 out of the 21 (95%) squamous-cell carcinoma tissues, including 13 cases of HPV-16, 0 case of HPV-18, and 7 cases of other HPV types. In the other 5 adenocarcinoma tissues, 3 had HPV type-18 DNA and 2 had no detectable HPV DNA. The distribution of HPV DNA in bulky tumors was not statistically different from that in the other 228 squamous-cell carcinomas and 23 adencarcinomas of smaller size operated upon during the same period. Out of the 26 patients, 9 (35%) had lymph node metastasis at the time of operation. During the follow-up period ranging from 19 to 48 months, 9 patients had recurrence and 7 of them died of disease. The distribution of HPV types was not related to the prognosis in these patients. There were no p53 mutations detected in all the 26 samples. Thus, HPV type and the status of p53 could not serve as additional prognostic factors in stage IB bulky cervical cancers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- HPV:
-
human papillomavirus
- PCR-SSCP:
-
polymerase chain reaction/single-strand confirmation polymorphism
References
Barnes W, Delgado G, Kurman RJ, Petrilli ES, Smith DM, Ahmed S, Lorincz AT, Temple GF, Jenson AB, Lancaster WD (1988) Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 29:267–273
Boronow RC (1991) Should whole pelvic radiation become past history? A case for the routine use of extended field therapy and multimodality therapy. Gynecol Oncol 43:71–76
Busby-Earle RMC, Steel CM, Williams ARW, Cohen B, Bird CC (1992) Papillomavirus, p53, and cervical cancer (letter). Lancet 339:1350
Chen TM, Chen CA, Hsieh CY, Chang DY, Chen YH, Defendi V (1993) The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Oncogene 8:1511–1518
Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R (1980) Analysis of factors contributing to treatment failures in stage Ib and IIa carcinoma of the cervix. Am J Obstet Gynecol 138:550–556
Chung CK, Nahhas WA, Zaino R, Stryker JA, Mortel R (1981) Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix. Gynecol Oncol 12:348–354
Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH (1992) Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 339:1070–1073
Fuginaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fuginaga K (1991) Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72:1039–1044
Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991) p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chromic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413–5417
Gallion HH, van Nagell JR Jr., Donaldson ES, Hanson MB, Powell DE, Maruyama Y, Yoneda J (1985) Combined radiation therapy and extrafascial hysterectomy in the treatment of stage Ib barrel-shaped cervical cancer. Cancer 56:262–265
Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW Jr, Hatch KD (1985) Identification of histopathologic risk groups in stage Ib squamous-cell carcinoma of the cervix. Obstet Gynecol 66:569–574
Girardi F, Fuchs P, Haas J (1992) Prognostic importance of human papillomavirus type 16 DNA in cervical cancer. Cancer 69:2502–2504
Hausen H zur (1987) Papilloma viruses in cancer. Cancer 59:1692–1696
Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ (1991) Increase age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910–913
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutation in human cancers. Science 253:49–53
Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in nodenegative breast cancer patients. J Natl Cancer Inst 84:1109–1114
King LA, Tase T, Twiggs LB, Okagaki T, Savage JE, Adcock LL, Prem KA, Carson LF (1989) Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer 63:897–900
Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD (1987) Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 79:671–677
Martinbeau PW, Kjorstad KE Iversen T (1982) Stage Ib carcinoma of the cervix, the Norwegian Radium Hospital. II. Results when pelvic nodes are involved. Obstet Gynecol 60:215–218
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strain confirmation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770
Panici PB, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A, Conte M, Battaglia F, Laurelli G, Rabitti C, Capelli A, Mancuso S (1991) Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67:372–379
Piver MS, Chung WS (1975) Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46:507–510
Rettenmaier MA, Casanova DM, Micha JP, Moran MF, Ramsanghani NS, Syed NA, Puthawala A, DiSaia PJ (1989) Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1b cervical cancer. Cancer 63:2220–2223
Rose BR, Thompson CH, Cossart YE, Elliot PE, Tattersall MHN (1991) Papillomavirus DNA and prognosis in cervical cancer (letter). Lancet 337:489
Sardi J, Sananes C, Giaroli A, Maya G, DiPaola G (1990) Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38:486–493
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523–5527
Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF, Chang EH (1992) The status of the p53 gene in human papillomavirus positive or negative cervical carcinoma cell lines. Carcinogenesis 13:1273–1275
Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845–855
Ting Y, Manos MM (1990) Detection and typing of genital human papillomavirueses. In: Innis MA, Gelfand DH, Sninsky JJ (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego, pp 356–367
Author information
Authors and Affiliations
Additional information
Funded by a grant from the National Taiwan University Hospital NTUH-82070-B26
Rights and permissions
About this article
Cite this article
Chen, CA., Chen, TM., Wu, CC. et al. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer. J Cancer Res Clin Oncol 120, 678–682 (1994). https://doi.org/10.1007/BF01245381
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245381